MLC901 for Moderate to Severe Traumatic Brain Injury (Specified Drug Code)
Clinical trial NCT04487275 · UNKNOWN
Trial details
- NCT number
- NCT04487275
- Sponsor
- Ali Amini Harandi
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-20
- Primary completion
- 2020-09-01
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.